CCR5 expression level has been studied in correlation with cognitive deficits in PWH, since patients treated with maraviroc, a CCR5 antagonist, have shown improvement in neurocognitive function (Ndhlovu et al. 2014; Gates et al. 2016; Barber et al. 2018). Here, CCR5 is linked to Cognitive impairment.